These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24938766)

  • 1. B-cell expansion and lymphomagenesis induced by chronic CD40 signaling is strictly dependent on CD19.
    Hojer C; Frankenberger S; Strobl LJ; Feicht S; Djermanovic K; Jagdhuber F; Hömig-Hölzel C; Ferch U; Ruland J; Rajewsky K; Zimber-Strobl U
    Cancer Res; 2014 Aug; 74(16):4318-28. PubMed ID: 24938766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.
    Graham JP; Arcipowski KM; Bishop GA
    Immunol Rev; 2010 Sep; 237(1):226-48. PubMed ID: 20727039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
    Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
    Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.
    Panagopoulos D; Victoratos P; Alexiou M; Kollias G; Mosialos G
    J Virol; 2004 Dec; 78(23):13253-61. PubMed ID: 15542676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
    Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death.
    Hollmann CA; Owens T; Nalbantoglu J; Hudson TJ; Sladek R
    Cancer Res; 2006 Apr; 66(7):3550-7. PubMed ID: 16585179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.
    Hömig-Hölzel C; Hojer C; Rastelli J; Casola S; Strobl LJ; Müller W; Quintanilla-Martinez L; Gewies A; Ruland J; Rajewsky K; Zimber-Strobl U
    J Exp Med; 2008 Jun; 205(6):1317-29. PubMed ID: 18490492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV.
    Lu KT; Dryer RL; Song C; Covey LR
    J Leukoc Biol; 2005 Sep; 78(3):620-9. PubMed ID: 15961576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
    Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
    J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
    Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
    Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.
    Burington B; Yue P; Shi X; Advani R; Lau JT; Tan J; Stinson S; Stinson J; Januario T; de Vos S; Ansell S; Forero-Torres A; Fedorowicz G; Yang TT; Elkins K; Du C; Mohan S; Yu N; Modrusan Z; Seshagiri S; Yu SF; Pandita A; Koeppen H; French D; Polson AG; Offringa R; Whiting N; Ebens A; Dornan D
    Sci Transl Med; 2011 Mar; 3(74):74ra22. PubMed ID: 21411738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
    Eliopoulos AG; Dawson CW; Mosialos G; Floettmann JE; Rowe M; Armitage RJ; Dawson J; Zapata JM; Kerr DJ; Wakelam MJ; Reed JC; Kieff E; Young LS
    Oncogene; 1996 Nov; 13(10):2243-54. PubMed ID: 8950992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling.
    Jacquot S; Kobata T; Iwata S; Morimoto C; Schlossman SF
    J Immunol; 1997 Sep; 159(6):2652-7. PubMed ID: 9300684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.
    Stunz LL; Busch LK; Munroe ME; Sigmund CD; Tygrett LT; Waldschmidt TJ; Bishop GA
    Immunity; 2004 Aug; 21(2):255-66. PubMed ID: 15308105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RelB contributes to the survival, migration and lymphomagenesis of B cells with constitutively active CD40 signaling.
    Kuhn LB; Valentin S; Stojanovic K; Strobl DC; Babushku T; Wang Y; Rambold U; Scheffler L; Grath S; John-Robbert D; Blum H; Feuchtinger A; Blutke A; Weih F; Kitamura D; Rad R; Strobl LJ; Zimber-Strobl U
    Front Immunol; 2022; 13():913275. PubMed ID: 36110848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1.
    Rastelli J; Hömig-Hölzel C; Seagal J; Müller W; Hermann AC; Rajewsky K; Zimber-Strobl U
    Blood; 2008 Feb; 111(3):1448-55. PubMed ID: 18006702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells.
    Li YY; Baccam M; Waters SB; Pessin JE; Bishop GA; Koretzky GA
    J Immunol; 1996 Aug; 157(4):1440-7. PubMed ID: 8759724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth.
    Baxendale AJ; Dawson CW; Stewart SE; Mudaliar V; Reynolds G; Gordon J; Murray PG; Young LS; Eliopoulos AG
    Oncogene; 2005 Nov; 24(53):7913-23. PubMed ID: 16091748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.